Reisner, S. L., Pletta, D. R., Mayer, K. H., Deutsch, M. B., Poteat, T., Potter, J., Wirtz, A. L., Harris, A., Campbell, J., Keuroghlian, A. S., Hughto, J. M. W., Gonzalez, A., & Radix, A. E. (2025). HIV seropositivity and viral non-suppression in transgender, non-binary, and gender-diverse people in primary care receiving gender-affirming hormone therapy in the USA between 2013 and 2019 (LEGACY): an observational, longitudinal, cohort study. The Lancet HIV. https://doi.org/10.1016/s2352-3018(25)00004-9

Siberry, G. K., & Ruel, T. (2025). The treatment optimisation ODYSSEY for children with HIV. The Lancet HIV. https://doi.org/10.1016/s2352-3018(25)00033-5

Gengiah, T. N., & Abdool Karim, Q. (2024). Preventing HIV in young women in Africa. The Lancet HIV. https://doi.org/10.1016/s2352-3018(24)00309-6

Farahani, M., Farley, S. M., Smart, T. F., Ndagije, F., Maile, L., Longwe, H., Hoos, D., & El-Sadr, W. M. (2024). Lesotho’s progress towards UNAIDS 95-95-95 targets from 2016 to 2020: comparison of Population-based HIV Impact Assessments. The Lancet HIV. https://doi.org/10.1016/s2352-3018(24)00271-6

Edupuganti, S., Hurt, C. B., Stephenson, K. E., Huang, Y., Paez, C. A., Yu, C., Yen, C., Hanscom, B., He, Z., Miner, M. D., Gamble, T., Heptinstall, J., Seaton, K. E., Domin, E., Lin, B. C., McKee, K., Doria-Rose, N., Regenold, S., Spiegel, H., … Afemata, S. (2024). Safety, tolerability, pharmacokinetics, and neutralisation activities of the anti-HIV-1 monoclonal antibody PGT121.414.LS administered alone and in combination with VRC07-523LS in adults without HIV in the USA (HVTN 136/HPTN 092): a first-in-human, open-label, randomised controlled phase 1 trial. The Lancet HIV. https://doi.org/10.1016/s2352-3018(24)00247-9

Kuhn, L., Barnabas, S., Cotugno, N., Peay, H., Goulder, P., Cotton, M., Violari, A., Pahwa, S., Reddy, K., Tagarro, A., Otwombe, K., Fry, S., Vaz, P., Lain, M. G., Nhampossa, T., Archary, M., Maiga, A. I., Puthanakit, T., Kityo, C. M., … Rossi, P. (2024). Analytical treatment interruption in children living with HIV: position statement from the EPIICAL consortium. The Lancet HIV. https://doi.org/10.1016/s2352-3018(24)00157-7

Justman, J. E., & Abularrage, T. F. (2024). Insights on COVID-19 mortality and HIV from South Africa. The Lancet HIV, 11(2), e67–e68. https://doi.org/10.1016/s2352-3018(24)00001-8

Sobieszczyk, M. E., Mannheimer, S., Paez, C. A., Yu, C., Gamble, T., Theodore, D. A., Chege, W., Yacovone, M., Hanscom, B., Heptinstall, J., Seaton, K. E., Zhang, L., Miner, M. D., Eaton, A., Weiner, J. A., Mayer, K., Kalams, S., Stephenson, K., Julg, B., … Montefiori, D. (2023). Safety, tolerability, pharmacokinetics, and immunological activity of dual-combinations and triple-combinations of anti-HIV monoclonal antibodies PGT121, PGDM1400, 10-1074, and VRC07-523LS administered intravenously to HIV-uninfected adults: a phase 1 randomised trial. The Lancet HIV, 10(10), e653–e662. https://doi.org/10.1016/s2352-3018(23)00140-6

Mofenson, L. M., & Abrams, E. J. (2023). Crucial need for improved pharmacovigilance in pregnancy. The Lancet HIV, 10(9), e560–e562. https://doi.org/10.1016/s2352-3018(23)00146-7

Burke, R. M., Feasey, N., Rangaraj, A., Camps, M. R., Meintjes, G., El-Sadr, W. M., & Ford, N. (2023). Ending AIDS deaths requires improvements in clinical care for people with advanced HIV disease who are seriously ill. The Lancet HIV, 10(7), e482–e484. https://doi.org/10.1016/s2352-3018(23)00109-1

Rosenberg, N. E., Shook-Sa, B. E., Liu, M., Stranix-Chibanda, L., Yotebieng, M., Sam-Agudu, N. A., Hudgens, M. G., Phiri, S. J., Mutale, W., Bekker, L.-G., Moyo, S., Zuma, K., Charurat, M. E., Justman, J., & Chi, B. H. (2023). Adult HIV-1 incidence across 15 high-burden countries in sub-Saharan Africa from 2015 to 2019: a pooled analysis of nationally representative data. The Lancet HIV, 10(3), e175–e185. https://doi.org/10.1016/s2352-3018(22)00328-9

Csete, J., Elliott, R., & Bernard, E. J. (2023). So many harms, so little benefit: a global review of the history and harms of HIV criminalisation. The Lancet HIV, 10(1), e52–e61. https://doi.org/10.1016/s2352-3018(22)00248-x

Murphy, E., Doherty, M., El Sadr, W., Zaidi, I., Kamarazulman, A., Crowley, S., Anam, F. R., Modi, C., Castellanos, E., Garner, A., McCulloch, N., Taslim, A., “Amanita” Calderon Cifuentes, P., Ghys, P. D., Godfrey-Faussett, P., Frescura, L., & DeCock, K. M. (2022). Innovations, adaptations, and accelerations in the delivery of HIV services during COVID-19. The Lancet HIV, 9(12), e884–e886. https://doi.org/10.1016/s2352-3018(22)00268-5

Penazzato, M., Townsend, C. L., Sam-Agudu, N. A., Ruel, T. D., Archary, M., Bekker, A., Cressey, T. R., Colbers, A., Sugandhi, N., Rojo, P., Rakhmanina, N., Watkins, M., Frigati, L., Mukui, I., Hafiz, A., Vicari, M., Capparelli, E. V., Abrams, E. J., Abrams, E., … Watkins, M. (2022). Advancing the prevention and treatment of HIV in children: priorities for research and development. The Lancet HIV, 9(9), e658–e666. https://doi.org/10.1016/s2352-3018(22)00101-1

Jacobs, T. G., Schouwenburg, S., Penazzato, M., Archary, M., Ruel, T. D., van den Anker, J., Burger, D. M., Cressey, T. R., Abrams, E. J., Lyall, H., Bekker, A., Colbers, A., Burger, D., Bekker, A., Cressey, T., Hirt, D., Lutsar, I., Mcilleron, H., Standing, J., … Vitoria, M. (2022). What babies need: accelerating access to current and novel antiretroviral drugs in neonates through pharmacokinetic studies. The Lancet HIV, 9(9), e649–e657. https://doi.org/10.1016/s2352-3018(22)00121-7

Simonds, H. M., & Jacobson, J. S. (2022). Breast cancer survival in women living with HIV. The Lancet HIV, 9(3), e141–e142. https://doi.org/10.1016/s2352-3018(22)00010-8

Harris, T. G., Wu, Y., Parmley, L. E., Musuka, G., Mapingure, M. P., Chingombe, I., Mugurungi, O., Hakim, A., Gozhora, P., Miller, S. S., Lamb, M. R., Samba, C., & Rogers, J. H. (2022). HIV care cascade and associated factors among men who have sex with men, transgender women, and genderqueer individuals in Zimbabwe: findings from a biobehavioural survey using respondent-driven sampling. The Lancet HIV, 9(3), e182–e201. https://doi.org/10.1016/s2352-3018(21)00297-6

El-Bassel, N., Mukherjee, T. I., Stoicescu, C., Starbird, L. E., Stockman, J. K., Frye, V., & Gilbert, L. (2022). Intertwined epidemics: progress, gaps, and opportunities to address intimate partner violence and HIV among key populations of women. The Lancet HIV, 9(3), e202–e213. https://doi.org/10.1016/s2352-3018(21)00325-8

Teasdale, C. A., Zimba, R., Abrams, E. J., Sachathep, K., Ndagije, F., Nuwagaba-Biribonwoha, H., Musuka, G., Mugurungi, O., Maile, L., Mahy, M., & Low, A. (2022). Estimates of the prevalence of undiagnosed HIV among children living with HIV in Eswatini, Lesotho, Malawi, Namibia, Tanzania, Zambia, and Zimbabwe from 2015 to 2017: an analysis of data from the cross-sectional Population-based HIV Impact Assessment surveys. The Lancet HIV, 9(2), e91–e101. https://doi.org/10.1016/s2352-3018(21)00291-5

Santelli, J. S., Chen, I. S., Nabukalu, D., Lutalo, T., Spindler, E. J., Chang, L. W., Grabowski, M. K., Grilo, S. A., Kreniske, P., Wei, Y., Nalugoda, F., Hoffman, S., Maru, M., Chu, S., Ssewamala, F. M., Byansi, W., Kagaayi, J., Wawer, M. J., Gray, R. H., … Makumbi, F. (2022). HIV combination prevention and declining orphanhood among adolescents, Rakai, Uganda, 2001–18: an observational community cohort study. The Lancet HIV, 9(1), e32–e41. https://doi.org/10.1016/s2352-3018(21)00275-7

Ward, Z., Stone, J., Bishop, C., Ivakin, V., Eritsyan, K., Deryabina, A., Low, A., Cepeda, J., Kelly, S. L., Heimer, R., Cook, R., Altice, F. L., Litz, T., Terlikbayeva, A., El-Bassel, N., Havarkov, D., Fisenka, A., Boshnakova, A., Klepikov, A., … Vickerman, P. (2022). Costs and impact on HIV transmission of a switch from a criminalisation to a public health approach to injecting drug use in eastern Europe and central Asia: a modelling analysis. The Lancet HIV, 9(1), e42–e53. https://doi.org/10.1016/s2352-3018(21)00274-5